US Stock MarketDetailed Quotes

Zenas BioPharma (ZBIO)

Watchlist
  • 19.930
  • -2.630-11.66%
Close Jan 15 16:00 ET
  • 20.300
  • +0.370+1.85%
Post 20:01 ET
1.07BMarket Cap-4.43P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zenas BioPharma (ZBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
10M
-90.00%5M
5M
0
0
0
50M
0
Operating revenue
--0
--0
--10M
-90.00%5M
--5M
--0
--0
--0
--50M
--0
Cost of revenue
Gross profit
Operating expense
16.09%47.58M
38.94%55.16M
71.62%47.33M
118.92%168.89M
144.65%60.62M
185.09%40.98M
110.01%39.7M
44.49%27.58M
2.59%77.15M
30.49%24.78M
Selling and administrative expenses
76.79%13.18M
105.87%12.14M
151.67%12.42M
73.83%29.75M
162.92%11.47M
48.37%7.45M
47.74%5.9M
31.93%4.93M
26.68%17.11M
35.27%4.36M
-General and administrative expense
76.79%13.18M
105.87%12.14M
151.67%12.42M
73.83%29.75M
162.92%11.47M
48.37%7.45M
47.74%5.9M
31.93%4.93M
26.68%17.11M
35.27%4.36M
Research and development costs
2.60%34.4M
27.27%43.03M
54.18%34.92M
131.77%139.14M
140.75%49.16M
258.53%33.53M
126.66%33.81M
47.55%22.65M
-2.68%60.03M
29.51%20.42M
Operating profit
-16.09%-47.58M
-38.94%-55.16M
-35.36%-37.33M
-503.71%-163.89M
-124.48%-55.62M
-215.05%-40.98M
-110.01%-39.7M
-44.49%-27.58M
63.90%-27.15M
-30.49%-24.78M
Net non-operating interest income expense
Other net income (expense)
-264.80%-3.92M
71.59%2.96M
1,700.00%3.55M
175.74%7.33M
599.39%3.45M
14,962.50%2.38M
117.01%1.73M
-1,918.18%-222K
78.05%-9.68M
9,960.00%493K
Gain on sale of security
----
----
----
-182.00%-846K
--0
----
---152K
---694K
99.30%-300K
----
Special income (charges)
---5M
----
----
--0
--0
--0
----
----
-900.00%-10M
--0
-Less：Restructuring and merger&acquisition
----
----
----
--0
--0
--0
----
----
900.00%10M
--0
-Less:Other special charges
--5M
----
----
----
----
----
----
----
900.00%10M
--0
Other non- operating income (expenses)
-54.54%1.08M
57.70%2.96M
652.54%3.55M
1,210.10%8.18M
334.80%3.45M
14,962.50%2.38M
1,421.83%1.88M
4,390.91%472K
922.95%624K
15,960.00%793K
Income before tax
-33.40%-51.5M
-37.46%-52.2M
-21.50%-33.78M
-325.17%-156.56M
-114.84%-52.18M
-208.42%-38.61M
-30.74%-37.98M
-45.57%-27.8M
69.13%-36.82M
-27.86%-24.29M
Income tax
0
20K
-205K
42.52%429K
429K
0
0
0
301K
Net income
-33.40%-51.5M
-37.51%-52.22M
-20.77%-33.57M
-322.87%-156.99M
-113.95%-52.6M
-208.42%-38.61M
-30.74%-37.98M
-45.57%-27.8M
68.88%-37.12M
-29.45%-24.59M
Net income continuous Operations
-33.40%-51.5M
-37.51%-52.22M
-20.77%-33.57M
-322.87%-156.99M
-113.95%-52.6M
-208.42%-38.61M
-30.74%-37.98M
-45.57%-27.8M
68.88%-37.12M
-29.45%-24.59M
Minority interest income
Net income attributable to the parent company
-33.40%-51.5M
-37.51%-52.22M
-20.77%-33.57M
-322.87%-156.99M
-113.95%-52.6M
-208.42%-38.61M
-30.74%-37.98M
-45.57%-27.8M
68.88%-37.12M
-29.45%-24.59M
Preferred stock dividends
Other preferred stock dividends
0
Net income attributable to common stockholders
-33.40%-51.5M
-37.51%-52.22M
-20.77%-33.57M
-322.87%-156.99M
-113.95%-52.6M
-1,136.96%-38.61M
-30.74%-37.98M
-45.57%-27.8M
68.88%-37.12M
-29.45%-24.59M
Basic earnings per share
75.70%-1.22
-30.98%-1.25
-14.51%-0.8
-457.79%-11.89
10.84%-1.2587
-2,448.32%-5.02
42.78%-0.9544
36.29%-0.6986
76.98%-2.1316
-29.45%-1.4118
Diluted earnings per share
75.70%-1.22
-30.98%-1.25
-14.51%-0.8
-457.79%-11.89
10.84%-1.2587
-2,448.32%-5.02
42.78%-0.9544
36.29%-0.6986
76.98%-2.1316
-29.45%-1.4118
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0010M-90.00%5M5M00050M0
Operating revenue --0--0--10M-90.00%5M--5M--0--0--0--50M--0
Cost of revenue
Gross profit
Operating expense 16.09%47.58M38.94%55.16M71.62%47.33M118.92%168.89M144.65%60.62M185.09%40.98M110.01%39.7M44.49%27.58M2.59%77.15M30.49%24.78M
Selling and administrative expenses 76.79%13.18M105.87%12.14M151.67%12.42M73.83%29.75M162.92%11.47M48.37%7.45M47.74%5.9M31.93%4.93M26.68%17.11M35.27%4.36M
-General and administrative expense 76.79%13.18M105.87%12.14M151.67%12.42M73.83%29.75M162.92%11.47M48.37%7.45M47.74%5.9M31.93%4.93M26.68%17.11M35.27%4.36M
Research and development costs 2.60%34.4M27.27%43.03M54.18%34.92M131.77%139.14M140.75%49.16M258.53%33.53M126.66%33.81M47.55%22.65M-2.68%60.03M29.51%20.42M
Operating profit -16.09%-47.58M-38.94%-55.16M-35.36%-37.33M-503.71%-163.89M-124.48%-55.62M-215.05%-40.98M-110.01%-39.7M-44.49%-27.58M63.90%-27.15M-30.49%-24.78M
Net non-operating interest income expense
Other net income (expense) -264.80%-3.92M71.59%2.96M1,700.00%3.55M175.74%7.33M599.39%3.45M14,962.50%2.38M117.01%1.73M-1,918.18%-222K78.05%-9.68M9,960.00%493K
Gain on sale of security -------------182.00%-846K--0-------152K---694K99.30%-300K----
Special income (charges) ---5M----------0--0--0---------900.00%-10M--0
-Less：Restructuring and merger&acquisition --------------0--0--0--------900.00%10M--0
-Less:Other special charges --5M----------------------------900.00%10M--0
Other non- operating income (expenses) -54.54%1.08M57.70%2.96M652.54%3.55M1,210.10%8.18M334.80%3.45M14,962.50%2.38M1,421.83%1.88M4,390.91%472K922.95%624K15,960.00%793K
Income before tax -33.40%-51.5M-37.46%-52.2M-21.50%-33.78M-325.17%-156.56M-114.84%-52.18M-208.42%-38.61M-30.74%-37.98M-45.57%-27.8M69.13%-36.82M-27.86%-24.29M
Income tax 020K-205K42.52%429K429K000301K
Net income -33.40%-51.5M-37.51%-52.22M-20.77%-33.57M-322.87%-156.99M-113.95%-52.6M-208.42%-38.61M-30.74%-37.98M-45.57%-27.8M68.88%-37.12M-29.45%-24.59M
Net income continuous Operations -33.40%-51.5M-37.51%-52.22M-20.77%-33.57M-322.87%-156.99M-113.95%-52.6M-208.42%-38.61M-30.74%-37.98M-45.57%-27.8M68.88%-37.12M-29.45%-24.59M
Minority interest income
Net income attributable to the parent company -33.40%-51.5M-37.51%-52.22M-20.77%-33.57M-322.87%-156.99M-113.95%-52.6M-208.42%-38.61M-30.74%-37.98M-45.57%-27.8M68.88%-37.12M-29.45%-24.59M
Preferred stock dividends
Other preferred stock dividends 0
Net income attributable to common stockholders -33.40%-51.5M-37.51%-52.22M-20.77%-33.57M-322.87%-156.99M-113.95%-52.6M-1,136.96%-38.61M-30.74%-37.98M-45.57%-27.8M68.88%-37.12M-29.45%-24.59M
Basic earnings per share 75.70%-1.22-30.98%-1.25-14.51%-0.8-457.79%-11.8910.84%-1.2587-2,448.32%-5.0242.78%-0.954436.29%-0.698676.98%-2.1316-29.45%-1.4118
Diluted earnings per share 75.70%-1.22-30.98%-1.25-14.51%-0.8-457.79%-11.8910.84%-1.2587-2,448.32%-5.0242.78%-0.954436.29%-0.698676.98%-2.1316-29.45%-1.4118
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -